Search for a Cure
Search for a Cure
IAS 2017: VRC01 Antibody Can Delay But Not Prevent HIV Rebound
- Details
- Category: Search for a Cure
- Published on Wednesday, 09 August 2017 00:00
- Written by Liz Highleyman
A broadly neutralizing antibody modestly delayed the resurgence of viral replication following interruption of antiviral therapy (ART) started during very early infection, but all study participants ultimately experienced viral rebound, according to results presented at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
IAS 2017: South African Child Has Controlled HIV Off Treatment for 8.5 Years
- Details
- Category: Search for a Cure
- Published on Friday, 28 July 2017 00:00
- Written by Keith Alcorn
A 9-year-old South African child who was diagnosed with HIV infection at 1 month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus without anti-HIV drugs for 8 and a half years, scientists reported this week at the 9th IAS Conference on HIV Science (IAS 2017) in Paris.
Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 16 April 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2017 Conference on Retroviruses and Opportunistic infections (CROI 2017), February 13-16, 2017, in Seattle.
Full coverage listing by topic
4/16/17
Coverage of the 2017 Harm Reduction International Conference
- Details
- Category: HIV Treatment
- Published on Wednesday, 31 May 2017 00:00
- Written by HIVandHepatitis.com
HIVand Hepatitis.com coverage of the 2017 Harm Reduction International Conference, May 14-17, 2017, in Montreal.
5/31/17
CROI 2017: How Does Vedolizumab Antibody Therapy Lead to Sustained Viral Remission?
- Details
- Category: Search for a Cure
- Published on Thursday, 16 March 2017 00:00
- Written by Liz Highleyman
HIV and its monkey cousin SIV can carry the alpha-4 beta-7 integrin receptor in their outer envelope, which helps the virus enter gut cells during early infection, according to research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. This finding may help explain how an antibody against alpha-4 beta-7 produced sustained viral remission in monkeys.
Web Design and Development by